PAR

PAR DRUGS & CHEMICALS

Small Cap BSE: 12541325 NSE: PAR
₹154.6
1.7 (1.11%)
As on 30 September, 2022 | 03:18

Par Drugs & Chemicals Share Price

Par Drugs & Chemicals Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Start SIP in PAR DRUGS & CHEMICALS

Start SIP

Par Drugs & Chemicals Share Returns

  • Over 1 Month -6.7%
  • Over 3 Month 8.42%
  • Over 6 Month 1.34%
  • Over 1 Year -22.87%

Par Drugs & Chemicals Key Statistics

P/E Ratio 20.6
PEG Ratio -1
Market Cap Cr 190
Price to Book Ratio 3.2
EPS 7.5
Dividend 0
Relative Strength Index 35.89
Money Flow Index 23.86
MACD Signal -3.16
Average True Range 7.01

Par Drugs & Chemicals Investment Rating

  • Master Rating:
  • Par Drugs and Chemicals has an operating revenue of Rs. 75.07 Cr. on a trailing 12-month basis. An annual revenue growth of 23% is outstanding, Pre-tax margin of 17% is great, ROE of 15% is good. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 0 which is a POOR score indicating inconsistency in earnings, a RS Rating of 25 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at D+ which indicates heavy supply, Group Rank of 125 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of D is close to being the worst. Institutional holding has remained stable in the last reported quarter. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

EPS Strength

N/A

Price Strength

Buyer Demand

Group Rank

Par Drugs & Chemicals Financials
IndicatorMar 2022Dec 2021Sep 2021Jun 2021Mar 2021
Oper Rev Qtr Cr 2217201616
Operating Expenses Qtr Cr 1813161212
Operating Profit Qtr Cr 54444
Depreciation Qtr Cr 11111
Interest Qtr Cr 00000
Tax Qtr Cr 11111
Net Profit Qtr Cr 22224

Par Drugs & Chemicals Technicals

EMA & SMA

Current Price
154.6
1.7 (1.11%)
  • Bullish Moving Average
  • ___
  • 0
  • Bearish Moving Average
  • ___
  • 0
  • 20 Day
  • 161.83
  • 50 Day
  • 165.23
  • 100 Day
  • 165.79
  • 200 Day
  • 167.19
  • 20 Day
  • 164.68
  • 50 Day
  • 169.83
  • 100 Day
  • 161.79
  • 200 Day
  • 167.05

Par Drugs & Chemicals Resistance and Support

PIVOT
₹154.49
Resistance
First Resistance 156.97
Second Resistance 161.04
Third Resistance 163.52
RSI 35.89
MFI 23.86
MACD Single Line -3.16
MACD -4.32
Support
First Resistance 150.42
Second Resistance 147.94
Third Resistance 143.87

Par Drugs & Chemicals Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 7,873 248,787 31.6
Week 7,342 475,127 64.71
1 Month 10,619 680,902 64.12
6 Month 20,093 939,765 46.77

Par Drugs & Chemicals Result Highlights

Par Drugs & Chemicals Synopsis

NSE-Medical-Diversified

Par Drugs & Chemical is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 75.07 Cr. and Equity Capital is Rs. 12.30 Cr. for the Year ended 31/03/2022. Par Drugs & Chemicals Ltd. is a Public Limited Listed company incorporated on 26/02/1999 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L24117GJ1999PLC035512 and registration number is 035512.
Market Cap 190
Sales 75
Shares in Float 0.32
No of funds 1
Yield 0.72
Book Value 3.18
U/D Vol ratio 0.6
LTDebt / Equity 8
Alpha -0.06
Beta 0.62

Par Drugs & Chemicals

Owner NameJun-22Mar-22Dec-21Sep-21
Promoters 74.21%74.21%73.98%
Others 25.79%25.79%26.02%

Par Drugs & Chemicals Management

Name Designation
Mr. Falgun Vallabhbhai Savani Chairman & Managing Director
Mr. Jignesh Vallabhbhai Savani Executive Director & CEO
Mr. Ghanshayambhai Bhagvanbhai Savani Whole Time Director
Mrs. Nayna Jignesh Savani Non Executive Director
Mr. Pravin Manjibhai Bhayani Independent Director
Mrs. Kajal Chintanbhai Vaghani Independent Director
Mr. Krishna Mitulbhai Shah Independent Director
Mrs. Bintal Bhaveshkumar Shah Independent Director

Par Drugs & Chemicals Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Par Drugs & Chemicals Corporate Action

Date Purpose Remarks
2022-07-28 Others
2022-05-07 Audited Results
2022-02-07 Quarterly Results
2021-11-09 Quarterly Results & Interim Dividend
2021-06-10 Audited Results
Date Purpose Remarks
2021-04-28 Bonus Rs.0.00 issue in the ratio of 1:1 of Rs. 10/-.

Par Drugs & Chemicals FAQs

What is Share Price of Par Drugs & Chemicals ?

Par Drugs & Chemicals share price is ₹154 As on 30 September, 2022 | 03:04

What is the Market Cap of Par Drugs & Chemicals ?

The Market Cap of Par Drugs & Chemicals is ₹190.2 Cr As on 30 September, 2022 | 03:04

What is the P/E ratio of Par Drugs & Chemicals ?

The P/E ratio of Par Drugs & Chemicals is 20.6 As on 30 September, 2022 | 03:04

What is the PB ratio of Par Drugs & Chemicals ?

The PB ratio of Par Drugs & Chemicals is 3.2 As on 30 September, 2022 | 03:04

Q1FY23